Overview

• The RESTORE randomized trial enrolled over 1,000 Australian adults with chronic disabling low back pain and followed about 300 participants to a three-year endpoint.
• Participants who completed eight CFT sessions over six months reported significantly greater reductions in pain intensity and activity limitation than those receiving usual care.
• Outcomes for the CFT plus biofeedback group were statistically indistinguishable from CFT alone, confirming that biofeedback offers no added therapeutic advantage.
• Published in The Lancet Rheumatology in August 2025, the study delivers the first robust evidence of lasting benefits from a psychotherapy-based approach to chronic low back pain.
• Investigators and clinicians are now prioritizing clinician training, scaling up CFT delivery and assessing its effectiveness in more diverse international populations